BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury

• Olivia J. Marola,
• Sarah E. R. Yablonski,
• Peter G. Shrager,
• Robert W. Nickells,
• Richard T. Libby

Affiliations

Olivia J. Marola

Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center

Sarah E. R. Yablonski

Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center

Peter G. Shrager

Department of Neuroscience, University of Rochester

Robert W. Nickells

Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison

Richard T. Libby

Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center